Literature DB >> 3353114

Developmental regulation of ovarian-specific Mos expression.

E Keshet1, M P Rosenberg, J A Mercer, F Propst, G F Vande Woude, N A Jenkins, N G Copeland.   

Abstract

To gain better insight into the physiologic role of the Mos proto-oncogene in mice we have been studying the cell type and developmental specificity of its expression. It was previously shown that in adult mice, Mos is transcribed predominantly in ovaries and in haploid spermatids of the testes. Using in situ hybridization techniques we now show that in the ovary, Mos is expressed in oocytes, but not in somatic cells. In these analyses Mos transcripts are not detected in primary resting oocytes, but accumulate soon after the oocyte enters the growth phase. High levels of Mos RNA are present throughout oocyte growth and maturation. Mos RNA is also abundant in ovulated eggs prior to fertilization. Following fertilization, however, there is a dramatic loss of Mos RNA, as evidenced by the failure to detect hybridization in late one-cell embryos. The narrow developmental window for Mos transcription defined by this study suggests a role for ovarian Mos in one or more of the processes of oocyte growth, meiotic maturation, ovulation, or fertilization.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3353114

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  13 in total

1.  The transcription factor C/EBP-beta and its role in ovarian function; evidence for direct involvement in the ovulatory process.

Authors:  M Pall; P Hellberg; M Brännström; M Mikuni; C M Peterson; K Sundfeldt; B Nordén; L Hedin; S Enerbäck
Journal:  EMBO J       Date:  1997-09-01       Impact factor: 11.598

2.  The testis-specific transcript (ferT) of the tyrosine kinase FER is expressed during spermatogenesis in a stage-specific manner.

Authors:  E Keshet; A Itin; K Fischman; U Nir
Journal:  Mol Cell Biol       Date:  1990-09       Impact factor: 4.272

3.  Ha-rasVal-12,Thr-59 activates S6 kinase and p34cdc2 kinase in Xenopus oocytes: evidence for c-mosxe-dependent and -independent pathways.

Authors:  C B Barrett; R M Schroetke; F A Van der Hoorn; S K Nordeen; J L Maller
Journal:  Mol Cell Biol       Date:  1990-01       Impact factor: 4.272

4.  Microinjection of antisense c-mos oligonucleotides prevents meiosis II in the maturing mouse egg.

Authors:  S J O'Keefe; H Wolfes; A A Kiessling; G M Cooper
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

5.  Xenopus homolog of the mos protooncogene transforms mammalian fibroblasts and induces maturation of Xenopus oocytes.

Authors:  R S Freeman; K M Pickham; J P Kanki; B A Lee; S V Pena; D J Donoghue
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

6.  Mouse Mos protooncogene product is present and functions during oogenesis.

Authors:  R S Paules; R Buccione; R C Moschel; G F Vande Woude; J J Eppig
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

7.  Identification of a candidate c-mos repressor that restricts transcription of germ cell-specific genes.

Authors:  W Xu; G M Cooper
Journal:  Mol Cell Biol       Date:  1995-10       Impact factor: 4.272

8.  A mammalian dual specificity protein kinase, Nek1, is related to the NIMA cell cycle regulator and highly expressed in meiotic germ cells.

Authors:  K Letwin; L Mizzen; B Motro; Y Ben-David; A Bernstein; T Pawson
Journal:  EMBO J       Date:  1992-10       Impact factor: 11.598

9.  Differential occurrence of CSF-like activity and transforming activity of Mos during the cell cycle in fibroblasts.

Authors:  K Okazaki; M Nishizawa; N Furuno; H Yasuda; N Sagata
Journal:  EMBO J       Date:  1992-07       Impact factor: 11.598

10.  The 'second-codon rule' and autophosphorylation govern the stability and activity of Mos during the meiotic cell cycle in Xenopus oocytes.

Authors:  M Nishizawa; K Okazaki; N Furuno; N Watanabe; N Sagata
Journal:  EMBO J       Date:  1992-07       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.